Clindamycin Phosphate Inject · #27 of 35 active shortages by FDA posting duration
Brand: CLINDAMYCIN
FDA lists Clindamycin Phosphate Inject as Active Shortage (Sagent Pharmaceuticals).
Availability on file: Available
Clindamycin Phosphate Injection: Active Shortage
Available 25 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Clindamycin Phosphate Injection
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection
- Presentation
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)
- Package NDC
- 25021-115-04
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Mar 21, 2023
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
clindamycin
Side effects, interactions, warnings & more
Nearby, Other Clindamycin Shortage Records
Clindamycin Phosphate Injection
Sandoz Inc.
Injection
Clindamycin Phosphate Injection
Sandoz Inc.
Injection
Clindamycin Phosphate Injection
Sandoz Inc.
Injection
Clindamycin Phosphate Injection
Sandoz Inc.
Injection
Clindamycin Phosphate Injection
Sagent Pharmaceuticals
Injection
Clindamycin Phosphate Injection
Sagent Pharmaceuticals
Injection